Table 2 Event numbers and incidence density (ID) of the outcomes between the study cohorts
Variable | Treated cohort (n = 1531) | Untreated cohort (n = 1531) | P-value‡ |
|---|---|---|---|
All-cause mortality | |||
Follow-up (years), mean ± SD | 3.78 ± 2.66 | 3.61 ± 2.57 | |
Event number, n (%) | 110 (7.18) | 237 (15.48) | |
ID (95% CI)a | 19.00 (15.45–22.55) | 42.89 (37.43–48.35) | |
Hazard ratio (95% CI) | 0.45 (0.36–0.56) | Reference | <0.001 |
Acute myocardial infarction | |||
Follow-up (years), mean ± SD | 3.77 ± 2.66 | 3.59 ± 2.56 | |
Event number, n (%) | 12 (0.78) | 13 (0.85) | |
ID (95% CI)a | 2.08 (0.90–3.26) | 2.36 (1.08–3.65) | |
Hazard ratio (95% CI) | 0.92 (0.42–2.01) | Reference | 0.826 |
Ischemic stroke | |||
Follow-up (years), mean ± SD | 3.75 ± 2.64 | 3.58 ± 2.56 | |
Event number, n (%) | 17 (1.11) | 18 (1.18) | |
ID (95% CI)a | 2.96 (1.55–4.37) | 3.28 (1.77–4.80) | |
Hazard ratio (95% CI) | 0.91 (0.47–1.76) | Reference | 0.774 |
Hemorrhagic stroke | |||
Follow-up (years), mean ± SD | 3.77 ± 2.66 | 3.58 ± 2.55 | |
Event number, n (%) | 7 (0.46) | 23 (1.50) | |
ID (95% CI)a | 1.21 (0.31–2.11) | 4.19 (2.48–5.91) | |
Hazard ratio (95% CI) | 0.31 (0.13–0.71) | Reference | 0.006 |
New onset dialysis (n = 2583)b | |||
Study number | 1280 | 1303 | |
Follow-up (years), mean ± SD | 3.93 ± 2.75 | 3.61 ± 2.61 | |
Event number, n (%) | 27 (2.11) | 79 (6.06) | |
ID (95% CI)a | 5.37 (3.34–7.39) | 16.78 (13.08–20.48) | |
Hazard ratio (95% CI) | 0.31 (0.20–0.48) | Reference | <0.001 |